Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Risk and Onset Latency of Incident (New-onset) Epilepsy After Stroke in Post-9/11 U.S. Veterans: A Post-hoc Analysis of the Long-term Impact of Military-relevant Brain Injury Consortium (LIMBIC-CENC) Study Data
Epilepsy/Clinical Neurophysiology (EEG)
S19 - Epilepsy Clinical Trials and Long-term Studies (4:54 PM-5:06 PM)
008

Strokes are a known cause of epilepsy. The latency (i.e. time from stroke to onset of incident epilepsy) can be highly variable. This study uses data from LIMBIC-CENC (a study designed to examine long-term outcomes of mild TBI) to explore the relationship between stroke and subsequent new-onset epilepsy in post-9/11 Veterans.

To assess the risk and onset latency of incident epilepsy following stroke in post-9/11 U.S. veterans.

Post hoc analysis of the retrospective cohort LIMBIC-CENC Phenotype study. Participants had care documented for at least 3 years in DoD and 2 years in VHA (10/1/1999-9/30/2019) with follow-up data through 9/30/2020. Inclusion criteria: stroke ICD codes during the study period. New-onset epilepsy was defined by a validated algorithm using diagnostic codes and pharmacy records. Exclusion criteria: seizure history prior to stroke, anoxic brain injury within 7 days of stroke, and TBI with unclear severity.

Of the 2,530,847 post-9/11 Veterans, 28,196 (1.1%) participants met inclusion criteria for stroke and no prior history of seizures. 80.1% were male and median age was 44 years [IQR 33-52]. After stroke, 2,874 (10.2%) developed epilepsy and 1,566 (5.6%) died during the study period. The median latency to epilepsy onset after stroke was 9.5 months [IQR 0.7-37.2] and maximum latency was 196.2 months. Veterans with stroke who developed epilepsy were younger at the time of stroke (median 40.5 years [IQR 30-37.2]) than veterans who did not develop epilepsy and survived (median 44 [IQR 33-51]) and those who died during the study period (median 51 [IQR 42-60]).

At least 10% of Veterans who suffer strokes will subsequently develop epilepsy; 50% develop epilepsy within 9.5 months of stroke, while 25% develop epilepsy after prolonged latencies of more than 3 years (37.2 months).

Authors/Disclosures
Manaz Rezayee (Portland VA Research)
PRESENTER
Ms. Rezayee has nothing to disclose.
Jacqueline Hirschey, MD Dr. Hirschey has nothing to disclose.
Megan Amuan No disclosure on file
Zulfi Haneef, MD, MBBS, MRCP, FAAN Dr. Haneef has nothing to disclose.
Linda S. Williams, MD, FAAN (Roudebush VAMC) The institution of Dr. Williams has received research support from VA HSR&D.
Ian Stewart No disclosure on file
Elisabeth Wilde Elisabeth Wilde has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuropsychology. The institution of Elisabeth Wilde has received research support from CDMRP/DoD. The institution of Elisabeth Wilde has received research support from VA. The institution of Elisabeth Wilde has received research support from NIH. The institution of Elisabeth Wilde has received research support from Cohen Veteran Biosciences.
Eamonn Kennedy (University of Utah) No disclosure on file
Marissa Kellogg, MD, MPH (VA Portland Healthcare System, Dept of Neurology) Dr. Kellogg has nothing to disclose.
Mary Jo Pugh, PhD, RN, FAAN The institution of Dr. Pugh has received research support from Department of Defense, Epilepsy Research Program. The institution of Dr. Pugh has received research support from VA Health Services Research and Development Service. The institution of Dr. Pugh has received research support from VA Rehabilitation Research and Development Service. The institution of Dr. Pugh has received research support from Congressionally Directed Research Programs. The institution of Dr. Pugh has received research support from Sanofi.